Brasada Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Brasada Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,000	Closed	-$36K	–	309
2018 Q1	$36K	Hold	1,000	–	–	0.01%	203
2017 Q4	$32K	Buy	+1,000	New	+$34.3K	0.01%	209

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brasada Capital Management's LMAT Position: Q2 2018 in Review

Brasada Capital Management sold out of LeMaitre Vascular (LMAT) in Q2 2018, closing a stake of 1,000 shares — an estimated $36K sold.

Brasada Capital Management first reported a position in LMAT in Q4 2017 and held it in 2 quarters. The position peaked at $36K in Q1 2018. 166 funds tracked by Wall St. Rank hold LMAT as of Q2 2018.

Brasada Capital Management reported no remaining LeMaitre Vascular position as of Q2 2018 after selling out during the quarter.
Brasada Capital Management sold 1,000 LeMaitre Vascular shares in Q2 2018, an estimated $36K.
Brasada Capital Management first reported a position in LeMaitre Vascular in Q4 2017 and held it in 2 quarters.
Brasada Capital Management's LeMaitre Vascular position peaked at $36K in Q1 2018.
166 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2018.

Based on Brasada Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.